Quick Summary
Livonibe 200mg Tablet 30's
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹1050
MRP: ₹2520
(You Save ₹1470)
30 TABLET(s) IN A BOTTLE
Livonibe 200mg Tablet 30's
Salt Composition
SORAFENIBMarketer
BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
58% OFF
₹1050
MRP: ₹2,520.00
Inclusive of all taxes
58% Off
Dispatch: Today
Care delivered without the wait. Your order is prioritized for rapid dispatch to ensure it reaches your doorstep on time.
Substitutes
Soranamo 200mg Tablet
SHIVNAAM TRADEL...
₹ 24.99/tablet
28% cheaper
Livonibe 200mg Tablet
BDR PHARMACEUTI...
₹ 28.53/tablet
18% cheaper
Soralieva 200mg Tablet
Allieva Pharma ...
₹ 30.83/tablet
11% cheaper
Sorafekast 200mg Tablet 30's
APRAZER HEALTHC...
₹ 31.37/tablet
10% cheaper
Introduction to Livonibe 200mg Tablet 30's
Livonibe tablet belongs to the group of medicines called anti-cancer. It consists of the active ingredient Sorafenib, which is indicated for advanced renal cell carcinoma (kidney cancer), advanced hepatocellular carcinoma (liver cancer) in patients ineligible for surgery and differentiated thyroid carcinoma (thyroid cancer) in patients who are not responsive to radioactive iodine therapy.
Diarrhea, tiredness, stomach pain, nausea, weakness, rashes, flu-like illness, appetite loss, nausea, weight loss, and low blood calcium levels are common side effects of Livonibe tablet. Inform your doctor if any of these side effects disturb or persist with you.
Inform your doctor if you are allergic to livonibe tablet and its ingredients. Before starting treatment with livonibe tablet, you should let your physician know if you have heart problems, chest pain, bleeding problems, high blood pressure, or have had or are about to have surgery. Use effective contraception during the therapy and for 6 months after the last dose if you are a woman or 3 months after the last dose if you are a man.
Uses of Livonibe 200mg Tablet 30's
Livonibe tablet is used to treat:
- Advanced renal cell carcinoma
- Advanced hepatocellular carcinoma that cannot be surgically treated
- Advanced papillary and follicular Hurtle cell thyroid carcinoma
Therapeutic Effects of Livonibe 200mg Tablet 30's
Livonibe tablet is a small molecule that works by inhibiting multiple receptor tyrosine kinases (enzymes), primarily vascular endothelial growth factor receptors and platelet-derived growth factor-β receptors. This prevents the development of blood vessels in tumour cells (angiogenesis) and arrests the growth and spread of the tumour cells to other organs.
Interaction of Livonibe 200mg Tablet 30's with other drugs
Inform your doctor about any medications you are taking or have taken before the treatment.
More Information about Livonibe 200mg Tablet 30's
Store below 30°C in a dry place.
How to consume Livonibe 200mg Tablet 30's
Take the tablet without food (1 hour before or 2 hours after meal). Swallow with a glass of water.
Safety Advice for Livonibe 200mg Tablet 30's
Breast Feeding
Do not breastfeed during treatment with a livonibe tablet and for two weeks after the last dose. It is vital to let your physician know if you are breastfeeding or planning to breastfeed before starting treatment with this drug.
Alcohol
Avoid consuming alcohol with livonibe tablet as it may cause unpleasant side effects.
Liver
Individuals with liver disease should consult a healthcare provider, especially those with liver conditions.
Lungs
Individuals with lung conditions should consult a healthcare provider, especially those with liver conditions.
Driving
This medicine could cause peripheral sensory neuropathy that causes an impact on driving. Hence, avoid driving or doing things that require focus during this treatment period.
Pregnancy
It is unsafe to use livonibe tablet during pregnancy as it may harm the unborn baby. Inform your physician before starting this treatment if you are pregnant or think you might be pregnant. Your physician will conduct a pregnancy test before prescribing this medicine for you.
Side Effects of Livonibe 200mg Tablet 30's
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Serious:
- Stevens Johnsons Syndrome and toxic epidermal necrosis
- Decreased blood flow to the heart
- Increased risk of bleeding (blood in urine, stool, vomit, cough, etc)
- High BP
- Skin problems
- Liver problems
- Problems in wound healing
Common:
- Nausea, stomach pain, diarrhea
- Tiredness and weakness
- Infection
- Hair thinning and patchy hair loss
- Rash
- Weight loss
- Loss of appetite
- Low levels of calcium in the blood
- Flu-like illness
Word of Advice
It is advised to seek immediate medical attention if your face swelling in your lower legs, or fast heartbeats, trouble breathing. It may be a sign of a heart problems. It may result in bleeding hence inform your doctor if you see blood in stools or urine.
FAQs about Livonibe 200mg Tablet 30's
Q1.
Can a diabetic person take a Livonibe tablet?
Yes, the livonibe tablet is safe to be taken by a diabetic individual. However, only take after seeing a doctor, as they may change the dose based on the patient's condition.
Q2.
What are the conditions in which livonibe tablet use is prohibited?
Livonibe tablet is not recommended for people who are allergic to any of its ingredients, have squamous cell lung cancer, or are already taking carboplatin and paclitaxel.
Q3.
When should I stop taking livonibe tablet as a treatment?
Livonibe tablet should be discontinued if a person experiences a major adverse effect that impairs their quality of life. If not, you must continue taking this medication until your physician instructs you to stop.
Q4.
What class of medication is livonibe tablet?
Livonibe tablet belongs to the group of medicines called anti-tumor and tyrosine kinase inhibitors.
Q5.
Can I use alcohol while taking a livonibe tablet?
Livonibe tablet is not to be taken with alcohol as it may cause unpleasant side effects.
Fact Box of Livonibe 200mg Tablet 30's
| Molecule name: Sorafenib | Therapeutic Class : Tyrosine kinase inhibitors |
Pharmacological class: Antineoplastics | Indication:
|
References
- Bayer (Pty) Ltd, [Revised on 22nd Apr 2016] [Accessed on 22 Nov 2022], https://www.bayer.com/sites/default/files/NEXAVAR_200_EN_PI.pdf
- Bayer HealthCare Pharmaceuticals Inc., US Food & Drug Administration, [Revised on Dec 2018] [Accessed on 22 Nov 2022]], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021923s020lbl.pdf
- Ciplamed, [Revised on Dec 2017] [Accessed on 22 Nov 2022]], https://www.ciplamed.com/print-product-pdf/24207
- Edward Chu, Cancer Chemotherapy, Lange’s Basic and Clinical Pharmacology, 14th Edition, 2018, 948-976.
- KD Tripathi, Anticancer Drugs, Essentials of Medical Pharmacology, 8th Edition, 2019, 915-936.
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Deva Prasath S.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
